Aminologics Co.,Ltd. (KOSDAQ:074430)

Aminologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24,896	18,882	11,999	12,738	8,861	8,580
Short-Term Investments	32,500	16,500	16,500	16,500	16,500	16,500
Trading Asset Securities	4,021	-	-	-	302.04	302.62
Cash & Short-Term Investments	61,417	35,382	28,499	29,238	25,663	25,383
Cash Growth	76.32%	24.15%	-2.53%	13.93%	1.10%	2.58%
Accounts Receivable	5,790	4,498	8,241	5,384	6,334	4,736
Other Receivables	640.09	151.8	175.94	260.15	155.36	42.08
Receivables	6,430	4,650	8,417	5,644	6,489	4,790
Inventory	5,864	6,083	7,977	8,335	6,373	5,103
Prepaid Expenses	131.05	213.72	189.9	285.58	83.86	1.05
Other Current Assets	2,410	188.02	166.43	66.39	69.7	48.02
Total Current Assets	76,251	46,517	45,249	43,569	38,679	35,325
Property, Plant & Equipment	2,710	3,090	2,630	2,826	2,120	1,585
Long-Term Investments	795.92	3,905	4,988	4,368	5,101	3,837
Other Intangible Assets	3,032	3,046	4,054	4,074	17,598	19,119
Long-Term Accounts Receivable	-0	-	-	-	-	-
Long-Term Deferred Tax Assets	-	-	515.44	520.95	1,522	-
Other Long-Term Assets	237.05	231.23	231.48	224.05	221.75	262.73
Total Assets	83,026	56,789	57,668	55,582	65,243	60,129
Accounts Payable	1,653	2,459	648.71	1,550	3,674	3,578
Accrued Expenses	326.4	288.89	247.74	207.15	159.36	160.78
Short-Term Debt	12,382	1,000	1,000	1,000	1,000	1,000
Current Portion of Leases	233.51	283.66	229.42	239.59	185.74	156.14
Other Current Liabilities	11,733	310.79	541.65	431.99	362.01	1,151
Total Current Liabilities	26,328	4,342	2,668	3,429	5,381	6,047
Long-Term Leases	587.87	734.77	589.53	749.49	468.03	524.02
Long-Term Unearned Revenue	33.08	17.12	-	-	-	-
Other Long-Term Liabilities	0	-0	-	0	-	-
Total Liabilities	26,948	5,094	3,257	4,178	5,849	6,571
Common Stock	8,783	8,783	8,783	8,783	8,783	8,783
Additional Paid-In Capital	118,400	118,400	118,400	118,400	118,400	118,400
Retained Earnings	-69,672	-73,997	-72,377	-74,814	-67,532	-72,892
Comprehensive Income & Other	-1,433	-1,490	-394.49	-965.24	-257.89	-733.3
Shareholders' Equity	56,078	51,695	54,411	51,404	59,393	53,558
Total Liabilities & Equity	83,026	56,789	57,668	55,582	65,243	60,129
Total Debt	13,203	2,018	1,819	1,989	1,654	1,680
Net Cash (Debt)	48,214	33,364	26,680	27,249	24,010	23,703
Net Cash Growth	47.18%	25.05%	-2.09%	13.49%	1.29%	3.45%
Net Cash Per Share	634.84	379.88	303.78	310.26	273.38	269.88
Filing Date Shares Outstanding	90.63	87.83	87.83	87.83	87.83	87.83
Total Common Shares Outstanding	90.63	87.83	87.83	87.83	87.83	87.83
Working Capital	49,924	42,175	42,581	40,140	33,298	29,278
Book Value Per Share	618.79	588.61	619.53	585.29	676.25	609.81
Tangible Book Value	53,046	48,649	50,357	47,330	41,795	34,439
Tangible Book Value Per Share	585.33	553.92	573.36	538.90	475.88	392.13
Land	281.84	281.84	281.84	281.84	281.84	153.26
Buildings	840.38	840.38	840.38	840.38	840.38	582.42
Machinery	7,569	7,584	7,033	6,864	6,349	6,046

Source: S&P Global Market Intelligence. Standard template. Financial Sources.